Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryvyl (RVYL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ryvyl (RVYL) over the last 12 years, with Q2 2025 value amounting to -$28000.0.

  • Ryvyl's Capital Expenditures fell 10534.35% to -$28000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 4469.03%. This contributed to the annual value of $1.6 million for FY2024, which is 142500.0% up from last year.
  • As of Q2 2025, Ryvyl's Capital Expenditures stood at -$28000.0, which was down 10534.35% from $1.1 million recorded in Q1 2025.
  • In the past 5 years, Ryvyl's Capital Expenditures registered a high of $1.1 million during Q1 2025, and its lowest value of -$28000.0 during Q2 2025.
  • Moreover, its 5-year median value for Capital Expenditures was $57303.0 (2021), whereas its average is $186109.3.
  • Within the past 5 years, the most significant YoY rise in Ryvyl's Capital Expenditures was 497272.73% (2025), while the steepest drop was 10534.35% (2025).
  • Quarter analysis of 5 years shows Ryvyl's Capital Expenditures stood at $61040.0 in 2021, then decreased by 1.7% to $60000.0 in 2022, then tumbled by 50.0% to $30000.0 in 2023, then skyrocketed by 1723.33% to $547000.0 in 2024, then plummeted by 105.12% to -$28000.0 in 2025.
  • Its Capital Expenditures stands at -$28000.0 for Q2 2025, versus $1.1 million for Q1 2025 and $547000.0 for Q4 2024.